Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulation of a pan-JAK inhibitor

Formulation of a pan-JAK inhibitor

US Patent 11795180 · Granted Oct 24, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl2025
Spirobicyclic analogues2024
Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyr2023
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl2023
JAK kinase inhibitor compounds for treatment of respiratory disease2023
Spirobicyclic analogues2023
Lisinopril compositions with an ingestible event marker2023
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-car2023
Administration of gut-selective JAK3 inhibitor2022
Combination dosage form of a mu opioid receptor antagonist and an opioid agent2022
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl2022
Lisinopril compositions with an ingestible event marker2021